These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4859623)

  • 21. Undetected latrogenic hypothyroidism: a late complication of radio-iodine therapy.
    Smidt KP; Johnston E
    N Z Med J; 1975 Apr; 81(537):325-8. PubMed ID: 1056550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Metabolic radiotherapy of hyperthyroidism].
    Salvatore M; Brunetti A
    Ann Ital Chir; 1989; 60(5):367-71. PubMed ID: 2699388
    [No Abstract]   [Full Text] [Related]  

  • 23. [Late results of treating thyrotoxicosis with 131I and post-therapeutic hypothyroidism].
    Khelds AO; Ozols VK; Shtelmane IA
    Med Radiol (Mosk); 1986 Mar; 31(3):24-7. PubMed ID: 2421127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of treating relapses of diffuse toxic goiter with radioactive iodine].
    Iaroslavtsev SA; Shvetsov SK
    Klin Med (Mosk); 1985 Dec; 63(12):70-3. PubMed ID: 3841571
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of RA 131I treatment protocols for Graves' disease.
    DeGroot LJ; Mangklabruks A; McCormick M
    J Endocrinol Invest; 1990 Feb; 13(2):111-8. PubMed ID: 2329258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early results of 125I therapy of thyrotoxic Graves' disease.
    Siemsen JK; Wallack MS; Martin RB; Nicoloff JT
    J Nucl Med; 1974 Apr; 15(4):257-60. PubMed ID: 4406129
    [No Abstract]   [Full Text] [Related]  

  • 28. Thyrotoxicosis--treatment by I131 therapy and early prediction of hypothyroidism following this therapy.
    Khanna CM; Jain SK; Walia RP
    J Assoc Physicians India; 1994 Jan; 42(1):36-8. PubMed ID: 7836246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioactive iodine therapy in Graves' hyperthyroidism: a prospective study from a tertiary referral centre in north India.
    Sankar R; Sekhri T; Sripathy G; Walia RP; Jain SK
    J Assoc Physicians India; 2005 Jul; 53():603-6. PubMed ID: 16190128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of hypothyroidism following small doses of 131I in the treatment of Graves' disease.
    McCullagh EP; Jelden GL; Rodriguez-Antunez A
    Ohio State Med J; 1976 Sep; 72(9):538-40. PubMed ID: 989600
    [No Abstract]   [Full Text] [Related]  

  • 31. Changing annual incidence of hypothyroidism after iodine-131 therapy for hyperthyroidism, 1951-1975.
    Holm LE
    J Nucl Med; 1982 Feb; 23(2):108-12. PubMed ID: 7057249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hematological changes in hyperthyroidism. A case report].
    Bertola G; Bocchia M; Ribotto P; Orlandini B; Torchio G
    Recenti Prog Med; 1998 Apr; 89(4):180-2. PubMed ID: 9612010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid diseases after treatment of Hodgkin's disease.
    Hancock SL; Cox RS; McDougall IR
    N Engl J Med; 1991 Aug; 325(9):599-605. PubMed ID: 1861693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anomalous plasma TSH levels in patients developing hypothyroidism in the early months after 131I therapy for thyrotoxicosis.
    Toft AD; Irvine WJ; Hunter WM; Ratcliffe JG; Seth J
    J Clin Endocrinol Metab; 1974 Sep; 39(3):607-9. PubMed ID: 4412033
    [No Abstract]   [Full Text] [Related]  

  • 37. [Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease].
    Sabri O; Schulz G; Zimny M; Schreckenberger M; Zimny D; Wagenknecht G; Kaiser HJ; Dohmen BM; Bares R; Büll U
    Nuklearmedizin; 1998 May; 37(3):83-9. PubMed ID: 9604227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combination of low doses of 131-iodine and synthetic antithyroid agents for prolonged treatment in Basedow's disease. Apropos of 165 cases].
    Mitouze J; Jaffiol C; Baldet L; Ghachem M
    Rev Fr Endocrinol Clin; 1972; 13(4):339-61. PubMed ID: 4122472
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diffuse toxic goiter treated with 131I. 30 years' experience].
    Rosas Guzmán J; González Treviño O; Luviano Vázquez C; Maisterrena J
    Rev Invest Clin; 1987; 39(1):11-8. PubMed ID: 3602662
    [No Abstract]   [Full Text] [Related]  

  • 40. Outcome following standardized 185 MBq dose 131I therapy for Graves' disease.
    Watson AB; Brownlie BE; Frampton CM; Turner JG; Rogers TG
    Clin Endocrinol (Oxf); 1988 May; 28(5):487-96. PubMed ID: 3214941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.